[A new concept of antidepressant drugs action: clinical and preclinical data].
The authors propose a new concept of antidepressant drug action based on adaptive receptor changes occurring in the course of chronic antidepressant treatment. Some clinical data and more equivocally preclinical studies indicate an enhancement of activity of those neurotransmitter systems which exert an activating impact on diverse cns functions (dopaminergic and alpha-1 adrenergic receptors). On the other hand the same treatment is found to inhibit the activity of central inhibitory systems (e.g. serotonergic and GABAergic receptors), thus resulting in an increase of positive reinforcement and psychomotor processes in the cns.
Płaźnik
A
A
Zakładu Farmakologii i Fizjologii Układu Nerwowego, Instytutu Psychiatrii i Neurologii w Warszawie.
Kostowski
W
W
D000928:Antidepressive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002395:Catecholamines / Q000378:metabolism; D003131:Combined Modality Therapy; D003866:Depressive Disorder / Q000188:drug therapy* / Q000628:therapy; D004298:Dopamine / Q000378:metabolism; D004565:Electroconvulsive Therapy; D006801:Humans; D008032:Limbic System / Q000187:drug effects; D018377:Neurotransmitter Agents / Q000378:metabolism; D011954:Receptors, Dopamine / Q000187:drug effects; D018079:Receptors, GABA / Q000187:drug effects; D011985:Receptors, Serotonin / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D000928:Antidepressive Agents; D002395:Catecholamines; D018377:Neurotransmitter Agents; D011954:Receptors, Dopamine; D018079:Receptors, GABA; D011985:Receptors, Serotonin; D012701:Serotonin; D005680:gamma-Aminobutyric Acid; D004298:Dopamine
Nowa koncepcja działania leków przeciwdepresyjnych: dane z kliniki i badań przedklinicznych.